Rezon Bio provides end-to-end biosimilar development and manufacturing support, from cell line development through (PPQ), BLA support, and commercial launch readiness. Our process development team covers cell line development, upstream and downstream development and optimization, scale-up from lab to GMP scale, analytical method development and validation, and full CMC documentation support for regulatory filings.
With a founding heritage in biosimilar development, including two commercially approved products, Rezon Bio has navigated this pathway multiple times under multiple global regulatory bodies, including FDA and EMA oversight and enabling fast commercial readiness. Programs are managed under a single quality system across both GMP sites, eliminating the handoff risk associated with multi-vendor approaches.
